Philips to nominate Mrs. Indra Nooyi as member of the Supervisory Board
We are very pleased to propose Mrs. Indra Nooyi as a new member of Philips Supervisory Board, said Jeroen van der Veer, Chairman of the Supervisory Board of Royal Philips.
October 26, 2020
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it will propose the appointment of Mrs. Indra Nooyi as a new member of the Supervisory Board to the Annual General Meeting of Shareholders (AGM), which will be held on May 6, 2021.
“We are very pleased to propose Mrs. Indra Nooyi as a new member of Philips’ Supervisory Board,” said Jeroen van der Veer, Chairman of the Supervisory Board of Royal Philips. “She is a proven business leader in the consumer and technology sectors, with a strong track record of delivering sustained profitable growth, while doing business sustainably and responsibly. Her strategic insights will be highly valuable to Philips, as the company embarks on its next growth phase as a health technology leader, with a purpose to improve the health and well-being of people through innovation.”
Mrs. Nooyi (American, 1955) is the former Chair and CEO of PepsiCo, a global food and beverages company with operations in over 180 countries and 2019 sales of USD 67 billion. During her tenure from 2006 till 2019, she was the chief architect of PepsiCo’s ‘Performance with Purpose’ pledge, and successfully delivered sustained growth by making more nutritious products, limiting its environmental footprint, and empowering its associates and people in the communities it serves. Prior to her appointment as CEO, Mrs. Nooyi held various executive leadership positions, including the role of CFO. Before joining PepsiCo in 1994, Mrs. Nooyi held strategy leadership positions at ABB, a leading global technology company, Motorola, a mobile communications pioneer, and the Boston Consulting Group.
For more information about Philips’ Supervisory Board, please follow this link.
For further information, please contact:
Steve Klink
Philips Global Press Office
Tel: +31 6 10888824
E-mail: s[email protected]
Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: [email protected]
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment
